FERG.UK

12,660

+0.08%↑

FERG.UK

12,660

+0.08%↑

FERG.UK

12,660

+0.08%↑

FERG.UK

12,660

+0.08%↑

FERG.UK

12,660

+0.08%↑

Search

ConvaTec Group PLC

Atvērts

SektorsFinanšu

258 1.1

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

252.8

Max

258.8

Galvenie mērījumi

By Trading Economics

Ienākumi

79M

Pārdošana

1.1B

P/E

Sektora vidējais

36.2

20.525

EPS

0.07

Dividenžu ienesīgums

2

Peļņas marža

7.059

Darbinieki

10,489

EBITDA

251M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+24.17% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

2.00%

4.36%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

126M

5.2B

Iepriekšējā atvēršanas cena

256.9

Iepriekšējā slēgšanas cena

258

ConvaTec Group PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 26. febr. 13:37 UTC

Tirgus saruna

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Salīdzinājums

Cenas izmaiņa

ConvaTec Group PLC Prognoze

Cenas mērķis

By TipRanks

24.17% augšup

Prognoze 12 mēnešiem

Vidējais 318.86 GBX  24.17%

Augstākais 375 GBX

Zemākais 305 GBX

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi ConvaTec Group PLC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

7 ratings

7

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.